Artigos

Search for articles

BJO Oncology - Placeholder

Crizotinib-Related Aseptic Abscesses in Lung Adenocarcinoma and -Gene Rearrangement: A Case Report ROS1

Abstract Crizotinib is a multi-tyrosine kinase inhibitor (mTKI) with efficacy in treating c-ROS oncogene 1-positive non-small cell lung cancer (NSCLC). The association between this TKI and the development of renal cysts is well established, although data on the formation of aseptic abscesses is scarce. We report a case of a...